EMB-01

· Shanghai EpimAb Biotherapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EMB-01, covering 2023-05-31 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients [Phase 2]